StudyFinder

Choline Supplementation as a Neurodevelopmental Intervention in Fetal Alcohol Spectrum Disorders Study

Recruiting

This is a double-blind randomized placebo-controlled clinical trial examining choline supplementation in 2-5 year old children with Fetal Alcohol Spectrum Disorders. Outcome measures are neurocognitive tests of memory, attention, and behavior.

I'm interested

Male or Female
Up to 18 years old
This study is NOT accepting healthy volunteers
Inclusion Criteria:

• ages 2.5 years to 5 years old (<6 years of age)
• prenatal alcohol exposure
Exclusion Criteria:

• history of a neurological condition (epilepsy, traumatic brain injury)
• history of a medical condition known to affect brain function
• other neurodevelopmental disorder (autism, Down syndrome)
• history of very low birthweight (<1500 grams)

Mental Health & Addiction

Fetal Alcohol Spectrum Disorders

Mary Anthony - antho248@umn.edu
Jeffrey Wozniak
Phase 2
SITE00000121
See this study on ClinicalTrials.gov

Back